Kewaunee Scientific (NASDAQ:KEQU) CEO Sells $80,500.68 in Stock

Key Points

• CEO Thomas David Hull III sold 1,854 shares of Kewaunee Scientific for approximately $80,500.68, reducing his ownership in the company by 4.46% and retaining 39,719 shares valued at over $1.7 million.
• Kewaunee Scientific's stock price is currently around $43.52, with a 1-year trading range between $30.33 and $71.33, and a market capitalization of $124.90 million.
• Wall Street analysts have upgraded the company from a "hold" to a "buy" rating, indicating a positive outlook for its performance moving forward.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,854 shares of the firm's stock in a transaction dated Monday, September 29th. The stock was sold at an average price of $43.42, for a total value of $80,500.68. Following the completion of the transaction, the chief executive officer directly owned 39,719 shares in the company, valued at $1,724,598.98. The trade was a 4.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total value of $43,620.00.
• On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The shares were sold at an average price of $44.00, for a total value of $31,724.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.34, for a total value of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Price Performance

NASDAQ KEQU traded up $0.87 during trading hours on Wednesday, reaching $43.52. The company's stock had a trading volume of 2,668 shares, compared to its average volume of 17,412. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. Kewaunee Scientific Corporation has a 1 year low of $30.33 and a 1 year high of $71.33. The firm's 50-day moving average price is $52.54 and its 200-day moving average price is $45.35. The company has a market capitalization of $124.90 million, a price-to-earnings ratio of 10.54 and a beta of 0.75.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million for the quarter.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Saturday, July 5th.

Institutional Investors Weigh In On Kewaunee Scientific

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bank of America Corp DE increased its holdings in shares of Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc grew its holdings in Kewaunee Scientific by 61.5% in the first quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after purchasing an additional 360 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Kewaunee Scientific in the second quarter valued at approximately $60,000. Wedbush Securities Inc. purchased a new position in shares of Kewaunee Scientific in the second quarter valued at approximately $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its position in shares of Kewaunee Scientific by 41.8% in the second quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company's stock valued at $247,000 after acquiring an additional 1,247 shares in the last quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.